Renee Gaeta, the Chief Financial Officer of $OM, sold 17,672 shares of the company on 06-03-2026 for an estimated $87,299. We received data on the trade from a recent SEC filing. This was a sale of approximately 13.4% of their shares of this class of stock. Following this trade, they now own 113,753 shares of this class of $OM stock.
$OM Insider Trading Activity
$OM insiders have traded $OM stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $OM stock by insiders over the last 6 months:
- LESLIE TRIGG (Chair and CEO) has made 0 purchases and 5 sales selling 22,515 shares for an estimated $102,761.
- RENEE GAETA (Chief Financial Officer) sold 17,672 shares for an estimated $87,299
- JOHN L. BROTTEM (General Counsel) has made 0 purchases and 5 sales selling 16,198 shares for an estimated $73,837.
- MARC NASH (EVP Operations R&D & Service) has made 0 purchases and 5 sales selling 9,862 shares for an estimated $44,801.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$OM Hedge Fund Activity
We have seen 57 institutional investors add shares of $OM stock to their portfolio, and 62 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. removed 1,614,582 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,199,994
- BML CAPITAL MANAGEMENT, LLC added 1,359,021 shares (+250.2%) to their portfolio in Q1 2026, for an estimated $5,218,640
- WOODLINE PARTNERS LP removed 1,033,418 shares (-77.9%) from their portfolio in Q1 2026, for an estimated $3,968,325
- DURABLE CAPITAL PARTNERS LP removed 1,023,706 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,797,949
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 631,663 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,343,469
- AQR CAPITAL MANAGEMENT LLC added 627,922 shares (+348.1%) to their portfolio in Q1 2026, for an estimated $2,411,220
- PARKMAN HEALTHCARE PARTNERS LLC removed 454,512 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,686,239
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$OM Revenue
$OM had revenues of $27.9M in Q1 2026. This is a decrease of -6.35% from the same period in the prior year.
You can track OM financials on Quiver Quantitative's OM stock page.
You can access data on OM stock through the Quiver Quantitative API.
$OM Analyst Ratings
Wall Street analysts have issued reports on $OM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/12/2026
To track analyst ratings and price targets for $OM, check out Quiver Quantitative's $OM forecast page.
$OM Price Targets
Multiple analysts have issued price targets for $OM recently. We have seen 3 analysts offer price targets for $OM in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Eric Winmill from Scotiabank set a target price of $1.5 on 02/26/2026
- Marie Thibault from BTIG set a target price of $15.0 on 02/12/2026
- Rick Wise from Stifel set a target price of $8.0 on 01/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
